Kawachi Pharmaceutical Reports Interim Operating Profit Down 6.2%
Consolidated operating profit for the September interim period was 30.09億円, down 6.2%. The forecast for the fiscal year ending March was 51.00億円, down 24.8%.
Consolidated operating profit for the September interim period was 30.09億円, down 6.2%. The forecast for the fiscal year ending March was 51.00億円, down 24.8%.